Search research articles
Contact Us
Filters
Showing results (31-40 of 92) with videos related to
Page
of 10
Sort By:
Histopathology
|
May 8, 2026
Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplification
Charlotte I Wang, Soma Jobbagy, Anne B Giersch, et al.
Scientific Reports
|
June 17, 2015
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
Yan Gao, Yong Feng, Jacson K Shen, et al.
Cancer
|
March 2, 2025
Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes - A systematic review and meta-analysis of randomized controlled trials
Megan H Goh, Marcos R Gonzalez, Hillary M Heiling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2020
A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas
Gregory M Cote, Edwin Choy, Tianqi Chen, et al.
Cancer
|
July 10, 2024
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma
Gregory M Cote, Anthony P Conley, Steven Attia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma
William D Tap, Gregory M Cote, Howard Burris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2018
Clinicopathologic characteristics of poorly differentiated chordoma
Angela R Shih, Gregory M Cote, Ivan Chebib, et al.
JCO Precision Oncology
|
February 17, 2022
Combined Targeted Therapy for <i>BRAF</i>-Mutant, Treatment-Related Acute Myeloid Leukemia
Seth A Wander, Robert P Hasserjian, Kwadwo Oduro, et al.
Cancer Research Communications
|
April 25, 2025
Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
Glenn J Hanna, Gregory M Cote, Rashmi Chugh, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 3, 2026
Multimodality Cardiovascular Imaging Reveals Late Recurrence of Cardiac Neoplasm
Midori N Torpoco Rivera, Hui Chong Lau, Joseph D Nguyen, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 92) with videos related to
Sort By:
Page
of 10
Histopathology
|
May 8, 2026
Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplification
Charlotte I Wang, Soma Jobbagy, Anne B Giersch, et al.
Scientific Reports
|
June 17, 2015
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
Yan Gao, Yong Feng, Jacson K Shen, et al.
Cancer
|
March 2, 2025
Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes - A systematic review and meta-analysis of randomized controlled trials
Megan H Goh, Marcos R Gonzalez, Hillary M Heiling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2020
A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas
Gregory M Cote, Edwin Choy, Tianqi Chen, et al.
Cancer
|
July 10, 2024
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma
Gregory M Cote, Anthony P Conley, Steven Attia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma
William D Tap, Gregory M Cote, Howard Burris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2018
Clinicopathologic characteristics of poorly differentiated chordoma
Angela R Shih, Gregory M Cote, Ivan Chebib, et al.
JCO Precision Oncology
|
February 17, 2022
Combined Targeted Therapy for <i>BRAF</i>-Mutant, Treatment-Related Acute Myeloid Leukemia
Seth A Wander, Robert P Hasserjian, Kwadwo Oduro, et al.
Cancer Research Communications
|
April 25, 2025
Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
Glenn J Hanna, Gregory M Cote, Rashmi Chugh, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 3, 2026
Multimodality Cardiovascular Imaging Reveals Late Recurrence of Cardiac Neoplasm
Midori N Torpoco Rivera, Hui Chong Lau, Joseph D Nguyen, et al.
Page
of 10